GuoWei Zhao

发表

Breaking boundaries: current progress of anticancer NK cell-based drug development.

Shuhang Wang, Yale Jiang, Kun Chen, 2022, Drug discovery today.

The clinical landscape of therapeutic cancer vaccines: the next breakthrough in cancer immunotherapy?

Peiwen J. Ma, Shuhang Wang, Yale Jiang, 2022, European journal of cancer.

Tectonic implications of Late Paleozoic stratigraphic distribution in Northeast China and adjacent region

Ning Li, Yuewu Sun, GuoWei Zhao, 2009 .

Coevolution of brachiopod paleobiogeography and tectonopaleogeography during the late Paleozoic in Central Asia

Ning Li, P. Zong, GuoWei Zhao, 2013, Science China Earth Sciences.

Adenovirotherapy delivering cross-hybrid IgGA Fc engineering PD-L1 inhibitors for enhanced cancer immunotherapy

Shuhang Wang, Ning Li, GuoWei Zhao, 2023, Molecular therapy oncolytics.

Membrane-based cancer nanovaccines: the time is now

Peiwen J. Ma, Shuhang Wang, Yale Jiang, 2023, QJM : monthly journal of the Association of Physicians.

Genetically predicted blood metabolites mediate the association between circulating immune cells and pancreatic cancer: A Mendelian randomization study

Yuan Fang, GuoWei Zhao, Yuanting Cai, 2024, The journal of gene medicine.

Unlocking the power of nanomedicine: Cell membrane-derived biomimetic cancer nanovaccines for cancer treatment.

Guangjun Nie, GuoWei Zhao, Shuhang Wang, 2024, Med.

Exosome-based anticancer vaccines: From Bench to Bedside.

Peiwen J. Ma, H. Miao, Yue Yu, 2024, Cancer letters.

Neoantigen-based Therapeutic Cancer Vaccine: Towards a bright future.

Peiwen J. Ma, Shujun Xing, GuoWei Zhao, 2023, Pharmacological research.

DNTGF-βR armored CAR-T cell therapy against tumors from bench to bedside

GuoWei Zhao, Yuning Wang, Shuhang Wang, 2024, Journal of translational medicine.

Pan-cancer analysis of polo-like kinase family genes reveals polo-like kinase 1 as a novel oncogene in kidney renal papillary cell carcinoma

Peiwen J. Ma, GuoWei Zhao, Yuning Wang, 2024, Heliyon.